The lawsuit revolved around Insulet's Omnipod tubeless insulin pump – used with continuous glucose monitors (CGMs) to create an artificial pancreas system used by diabetics – and claimed that ...

(Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced the Omnipod 5 Automated Insulin Delivery System is now ...

(Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced plans to release its financial results for the fourth quarter ...

Insulet Corporation PODD recently made its Omnipod 5 automated insulin delivery ... Omnipod 5 is recognized as the number one insulin pump for new pump users in Europe. Omnipod 5 is also the ...

The On-Body Drug Delivery Devices market is witnessing significant growth, driven by the increasing demand for ...

Acton, Massachusetts-based Insulet ... and sells insulin delivery systems for people with insulin-dependent diabetes. Valued at a market cap of $19.7 billion, the company’s Omnipod Insulin ...

January 13, 2025--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today ...